U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07900971) titled 'Transcutaneous Electrical Neurostimulation After Ablation of Essure(R)' on Oct. 21.
Brief Summary: The ESSURE(R) device is an implantable medical device for definitive and irreversible sterilization indicated for adult women of childbearing age. These implants are inserted into the fallopian tubes by hysteroscopy. Marketed in 2002, ESSURE(R) contraceptive implants were withdrawn from the French market in 2017 (and worldwide in 2017 and 2018) following the observation in certain patients of polymorphic and non-specific gynecological and extra-gynecological symptoms. The hypothesis would be a dissemination of the metallic elements con...